Clinical Trial Update: A Phase Ib Study of PRJ1-3024 for Treatment of Advanced or Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

Zhuhai Yufan Biotechnologies Co., Ltd. is conducting a Phase Ib/Phase II trial of PRJ1-3024 for advanced or metastatic melanoma. The study is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• PRJ1-3024

Snippet

Sponsor: Zhuhai Yufan Biotechnologies Co., Ltd | Conditions: Melanoma | Phase 1, Phase 2 | Status: RECRUITING